Crossmark

Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia

Crossref DOI link: https://doi.org/10.1007/s11899-026-00778-1

Published Online: 2026-04-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naderi, Zuhal https://orcid.org/0000-0002-6814-8007
Sadras, Teresa https://orcid.org/0000-0001-9048-9580
Branford, Susan https://orcid.org/0000-0002-5095-7981
Shanmuganathan, Naranie https://orcid.org/0000-0001-5895-8797
Pagani, Ilaria S. https://orcid.org/0000-0002-3216-2966
License Information

Text and Data Mining valid from 2026-04-25

Version of Record valid from 2026-04-25
More Information

Article History

Received: 14 January 2026

Accepted: 1 April 2026

First Online: 25 April 2026

Declarations

:

: The authors declare no competing interests.